tiprankstipranks
Analyst Profile
Followed by 403 other investors
.
Tycho Peterson

Tycho Peterson

J.P. Morgan
Wall Street Analyst
Ranked #737 out of 8,014 Analysts on TipRanks (#1,262 out of 21,455 overall experts)

Success Rate

57%
155 out of 270 Profitable Transactions

Average Return

9.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Tycho Peterson's ratings since 2014 and opened each position for the duration of 1 Year:
57.41% of your transactions would have been profitable with an average return of 9.1%

Stock Rating Distribution

395Ratings
60.51% Buy
28.10% Hold
11.39% Sell
Distribution of Tycho Peterson's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
10X Genomics
(TXG)
Rating Type:Buy
Dates:Oct 07, 2019 - Oct 07, 2020
Gain:189.50%
The most profitable rating made by Tycho Peterson

Tycho Peterson's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Sigma-Aldrich Corp
Hold
Initiated
0.00%
5
Cellular Dynamics
Buy
Assigned
67%
+25.23%
3
Covance Inc
Hold
Downgraded
100%
+14.80%
4
Sirona Dental
Hold
Assigned
0.00%
2
Affymetrix
Hold
Upgraded
0%
-37.00%
4
Cepheid
Hold
Reiterated
0.00%
2
Tempest Therapeutics
Hold
Reiterated
$8.00
(250.88% Upside)
0.00%
1
Foundation Medicine
Hold
Reiterated
0.00%
3
PerkinElmer
Hold
Reiterated
$50.00
(-69.16% Downside)
33%
-0.83%
7
Zeltiq Aesthetics
Hold
Assigned
0.00%
10
List of latest recommendations made by Tycho Peterson. Click to expand and see Tycho Peterson's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More